Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E Brier

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Clinical Pharmacology|May 21, 2010
Pharmacokinetics of dexrazoxane in subjects with impaired kidney functionMichael E Brier, Shari K Gaylor, J Patrick McGovren, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 31, 2010
Determining optimum hemoglobin sampling for anemia management from every-treatment dataAdam E Gaweda, Brian H Nathanson, Alfred A Jacobs, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|May 29, 2014
Barriers, biases, and beliefs about arteriovenous fistula placement in children: a survey of the International Pediatric Fistula First Initiative (IPFFI) within the Midwest Pediatric Nephrology Consortium (MWPNC)Deepa H Chand, Denis Geary, Hiren Patel, et al.
IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society|April 20, 2007
Using clinical information in goal-oriented learningAdam E Gaweda, Mehmet K Muezzinoglu, George R Aronoff, et al.
Neural Networks : the Official Journal of the International Neural Network Society|August 20, 2005
Individualization of pharmacological anemia management using reinforcement learningAdam E Gaweda, Mehmet K Muezzinoglu, George R Aronoff, et al.
Kidney International|December 15, 2010
Oncostatin M receptor β and cysteine/histidine-rich 1 are biomarkers of the response to erythropoietin in hemodialysis patientsMichael L Merchant, Adam E Gaweda, Andrew J Dailey, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Pharmacokinetics of linezolid in subjects with renal dysfunctionMichael E Brier, Dennis J Stalker, George R Aronoff, et al.
Plos One|July 22, 2017
Rate of hepatitis C viral clearance by human livers in human patients: Liver transplantation modeling primary infection and implications for studying entry inhibitionMichael G Hughes, William W Tucker, Sreelatha Reddy, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 29, 2003
Comparison of urea reduction ratio and hematocrit data reported in different data systems: results from the Centers for Medicare & Medicaid Services and the Renal Network IncDiane L Frankenfield, Michael E Brier, Marjorie R Bedinger, et al.
Scientific Reports|November 20, 2020
Serum trace metal association with response to erythropoiesis stimulating agents in incident and prevalent hemodialysis patientsMichael E Brier, Jessica R Gooding, James M Harrington, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pharmacology|May 21, 2010
Pharmacokinetics of dexrazoxane in subjects with impaired kidney functionMichael E Brier, Shari K Gaylor, J Patrick McGovren, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 31, 2010
Determining optimum hemoglobin sampling for anemia management from every-treatment dataAdam E Gaweda, Brian H Nathanson, Alfred A Jacobs, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|May 29, 2014
Barriers, biases, and beliefs about arteriovenous fistula placement in children: a survey of the International Pediatric Fistula First Initiative (IPFFI) within the Midwest Pediatric Nephrology Consortium (MWPNC)Deepa H Chand, Denis Geary, Hiren Patel, et al.
IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society|April 20, 2007
Using clinical information in goal-oriented learningAdam E Gaweda, Mehmet K Muezzinoglu, George R Aronoff, et al.
Neural Networks : the Official Journal of the International Neural Network Society|August 20, 2005
Individualization of pharmacological anemia management using reinforcement learningAdam E Gaweda, Mehmet K Muezzinoglu, George R Aronoff, et al.
Kidney International|December 15, 2010
Oncostatin M receptor β and cysteine/histidine-rich 1 are biomarkers of the response to erythropoietin in hemodialysis patientsMichael L Merchant, Adam E Gaweda, Andrew J Dailey, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2003
Pharmacokinetics of linezolid in subjects with renal dysfunctionMichael E Brier, Dennis J Stalker, George R Aronoff, et al.
Plos One|July 22, 2017
Rate of hepatitis C viral clearance by human livers in human patients: Liver transplantation modeling primary infection and implications for studying entry inhibitionMichael G Hughes, William W Tucker, Sreelatha Reddy, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 29, 2003
Comparison of urea reduction ratio and hematocrit data reported in different data systems: results from the Centers for Medicare & Medicaid Services and the Renal Network IncDiane L Frankenfield, Michael E Brier, Marjorie R Bedinger, et al.
Scientific Reports|November 20, 2020
Serum trace metal association with response to erythropoiesis stimulating agents in incident and prevalent hemodialysis patientsMichael E Brier, Jessica R Gooding, James M Harrington, et al.
Pageof 5